1. Home
  2. CVAC vs HQH Comparison

CVAC vs HQH Comparison

Compare CVAC & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • HQH
  • Stock Information
  • Founded
  • CVAC 2000
  • HQH 1986
  • Country
  • CVAC Germany
  • HQH United States
  • Employees
  • CVAC N/A
  • HQH N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • HQH Finance Companies
  • Sector
  • CVAC Health Care
  • HQH Finance
  • Exchange
  • CVAC Nasdaq
  • HQH Nasdaq
  • Market Cap
  • CVAC 764.4M
  • HQH 826.8M
  • IPO Year
  • CVAC 2020
  • HQH N/A
  • Fundamental
  • Price
  • CVAC $5.45
  • HQH $15.98
  • Analyst Decision
  • CVAC Hold
  • HQH
  • Analyst Count
  • CVAC 3
  • HQH 0
  • Target Price
  • CVAC $6.83
  • HQH N/A
  • AVG Volume (30 Days)
  • CVAC 2.2M
  • HQH 183.8K
  • Earning Date
  • CVAC 08-14-2025
  • HQH 01-01-0001
  • Dividend Yield
  • CVAC N/A
  • HQH 11.56%
  • EPS Growth
  • CVAC N/A
  • HQH N/A
  • EPS
  • CVAC 0.87
  • HQH 1.09
  • Revenue
  • CVAC $566,039,775.00
  • HQH N/A
  • Revenue This Year
  • CVAC N/A
  • HQH N/A
  • Revenue Next Year
  • CVAC $24.04
  • HQH N/A
  • P/E Ratio
  • CVAC $6.31
  • HQH $15.24
  • Revenue Growth
  • CVAC 787.60
  • HQH N/A
  • 52 Week Low
  • CVAC $2.37
  • HQH $14.31
  • 52 Week High
  • CVAC $5.72
  • HQH $17.94
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 65.07
  • HQH 59.25
  • Support Level
  • CVAC $5.36
  • HQH $15.50
  • Resistance Level
  • CVAC $5.45
  • HQH $15.90
  • Average True Range (ATR)
  • CVAC 0.08
  • HQH 0.24
  • MACD
  • CVAC -0.05
  • HQH 0.05
  • Stochastic Oscillator
  • CVAC 58.00
  • HQH 97.25

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Share on Social Networks: